<DOC>
	<DOCNO>NCT02279836</DOCNO>
	<brief_summary>The objective study gather post-market data regard performance invendo SC20 colonoscope real-world US population .</brief_summary>
	<brief_title>Single Arm Post-marketing Study SC20 Colonoscope</brief_title>
	<detailed_description>The objective study expand data collection product exposure control clinical setting gather data regard performance Invendo SC20 colonoscope real-world US population . The objective study specifically monitor three point : 1 . The diagnostic performance device include polyp adenoma detection rate ; 2 . The therapeutic performance device ( ability physician remove/biopsy identify lesion ) ; 3 . Performance device typical colonoscopy population , include patient underlie inflammatory bowel disease ( IBD ) , previous pelvic surgery irradiation , obesity , diverticular disease , previous colorectal surgery , present study population ( see C. ) .</detailed_description>
	<criteria>Any indication colonoscopy Willing give informed consent Willing consume 24 liter bowel prep An age young 18 year Congestive heart failure Renal insufficiency Intestinal obstruction Any acute lifethreatening condition ( opinion investigator ) Current pregnancy Abdominal surgery past 6 month Bleeding disorder Inability provide informed consent Any contraindication colonoscopy ( e.g . fulminant colitis acute diverticulitis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Patients indication colonoscopy U.S.A .</keyword>
</DOC>